Health & Safety Industry Today
Cancer Stem Cells Market size to Reach USD 5.07 Billion by 2031 as Targeted Oncology Research and Transplant Applications Strengthen Market Trends
Introduction
According to Mordor Intelligence, the cancer stem cells market size was valued at USD 2.63 billion in 2025 and is projected to reach USD 5.07 billion by 2031, supported by continued research activity and clinical interest in stem-cell-based cancer treatment approaches.
Cancer stem cells are a specific group of cells within tumors that can initiate tumor growth, survive therapy, and contribute to recurrence. Because of these characteristics, the cancer stem cells industry has become a critical focus area for researchers developing targeted oncology treatments. Companies and research institutions are studying these cells to improve treatment precision, enhance transplantation outcomes, and identify biomarkers that can guide therapy decisions.
Cancer Stem Cells Market Trends
Increasing Research on Tumor-Initiating Cells
One of the major cancer stem cells market trends is the rising focus on identifying tumor-initiating cells responsible for cancer recurrence. Researchers are increasingly studying these cells to understand how tumors grow, spread, and resist conventional therapies.
Expansion of Stem-Cell-Based Transplant Applications
Another important driver shaping cancer stem cells market trends is the increasing use of stem-cell-based transplant procedures for certain cancer treatments. Stem-cell transplantation remains an important therapy in oncology, particularly for blood cancers.
Growing Focus on Stem-Cell Sources and Manufacturing
The choice of stem-cell source is another factor influencing the cancer stem cells market forecast. Bone marrow remains one of the most widely used sources because of its established role in clinical practice.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/cancer-stem-cells-market?utm_source=industrytoday
Cancer Stem Cells Market Segmentation
By Cancer Type
- Breast cancer
- Blood cancer
- Lung cancer
- Brain cancer
- Colorectal cancer
- Pancreatic cancer
- Bladder cancer
- Liver cancer
- Other cancer types
By Application
- Autologous stem-cell transplantation
- Allogeneic stem-cell transplantation
By Stem-Cell Source
- Bone marrow
- Induced pluripotent stem cells
- Peripheral blood stem cells
- Umbilical cord blood
By Geography
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
Explore Our Full Library of Healthcare Research Report: https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=industrytoday
Cancer Stem Cells Market Key Players
The competitive landscape of the cancer stem cells market includes biotechnology companies, research technology providers, and pharmaceutical organizations involved in oncology research.
Key companies active in the cancer stem cells market include:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Lonza
- PromoCell GmbH
- Bio-Techne (R&D Systems, Inc.)
Conclusion
The outlook for the cancer stem cells market remains positive as oncology research continues to focus on tumor-initiating cells and their role in cancer progression. Researchers are increasingly exploring therapies designed to eliminate these cells in order to reduce recurrence and improve long-term treatment outcomes. Advances in cell analysis technologies, stem-cell culture methods, and transplantation procedures are strengthening the cancer stem cells market growth across research and clinical environments.
Overall, the combination of increasing research activity, clinical interest in stem-cell-based oncology treatments, and improved analytical technologies will continue to shape the cancer stem cells market size, positioning it as an important segment within the broader oncology research ecosystem.
Get detailed insights on the cancer stem cells market:
Industry Related Reports
Radiopharmaceutical CDMO/CMO Services Market:
Oral Solid Dosage CDMO Market Size:
Oncology Contract Research Organization (CRO) Market Share:
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
https://www.mordorintelligence.com/
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
